Cencora Q3: Growing Specialty Drug Distributions, Initiate At Buy

Group 1 - Cencora, Inc. (NYSE: COR), previously known as AmerisourceBergen, is identified as a leading U.S. pharmaceutical distributor [1] - The company is favored for its stable business model and strategic investments in digital platforms and specialty medications [1] - A Buy rating is initiated for the company based on its current positioning and future potential [1]